CTOs on the Move

Empathia

www.empathia.com

 
Empathia is a Waukesha, WI-based company in the Business Services sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.empathia.com
  • n17 Riverwood Dr Ste 300
    Waukesha, WI USA 53188
  • Phone: 866.332.9595

Executives

Name Title Contact Details

Similar Companies

LPA Inc.

As one of the largest integrated design firms in California, LPA Inc., has a distinct history of expertise in architecture, design and planning. Founded in 1965, LPA provides architectural, planning, landscape architecture, interior design, engineering, and graphic/signage services from early program development to project closeout. With extensive experience in public and private architecture, our firm designs a diversity of facilities that span from K-12 schools, colleges and universities, to civic, corporate, religious and retail establishments.

Strahm Automation and Mailing Services

Strahm Automation and Mailing Services is a Kansas City, MO-based company in the Business Services sector.

LSV Asset Management

LSV Asset Management is a Chicago, IL-based company in the Business Services sector.

Sequel Med Tech

Sequel Med Tech is a healthcare technology company based in Manchester, New Hampshire, dedicated to advancing drug delivery systems for diabetes management. The company focuses on creating innovative insulin delivery solutions that enhance the lives of people with diabetes. Their flagship product, the twiist™ Automated Insulin Delivery (AID) System, features advanced technology for precise insulin delivery and is designed for everyday wear. This system utilizes the Loop algorithm to automatically adjust insulin delivery, providing clinically meaningful benefits. Sequel Med Tech collaborates with healthcare providers, employers, and pharmaceutical companies to improve access to insulin therapy and develop new drug delivery solutions. They are actively working on integrating their twiist AID System with Abbott’s glucose-ketone sensor to enhance early detection of rising ketones, aiming to reduce the risk of diabetic ketoacidosis in individuals with type 1 diabetes. Through these efforts, Sequel Med Tech strives to simplify diabetes care and improve health outcomes for those who require insulin therapy.